OS Therapies Inc — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that OS Therapies Inc filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Net Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | ($6.88M) | Nov 14, 2025 |
| Q3 | 2025 | Jun 30, 2025 | ($4.54M) | Nov 14, 2025 |
| Q2 | 2025 | Jun 30, 2025 | ($4.54M) | Aug 18, 2025 |
| Q1 | 2025 | Mar 31, 2025 | ($3.88M) | May 15, 2025 |
| Q3 | 2025 | Mar 31, 2025 | ($3.88M) | Nov 14, 2025 |
| Q2 | 2025 | Mar 31, 2025 | ($3.88M) | Aug 18, 2025 |
| Q3 | 2025 | Sep 30, 2024 | ($2.88M) | Nov 14, 2025 |
| Q3 | 2025 | Jun 30, 2024 | ($1.56M) | Nov 14, 2025 |
| Q2 | 2025 | Jun 30, 2024 | ($1.56M) | Aug 18, 2025 |
| Q3 | 2025 | Mar 31, 2024 | ($1.46M) | Nov 14, 2025 |
| Q2 | 2025 | Mar 31, 2024 | ($1.46M) | Aug 18, 2025 |
| Q1 | 2025 | Mar 31, 2024 | ($1.46M) | May 15, 2025 |
| Q3 | 2024 | Sep 30, 2023 | ($1.97M) | Nov 15, 2024 |
| Q2 | 2024 | Jun 30, 2023 | ($2.51M) | Aug 14, 2024 |
| Q3 | 2024 | Jun 30, 2023 | ($2.51M) | Nov 15, 2024 |
| Q3 | 2024 | Mar 31, 2023 | ($1.85M) | Nov 15, 2024 |
| Q2 | 2024 | Mar 31, 2023 | ($1.85M) | Aug 14, 2024 |
| Q1 | 2024 | Mar 31, 2023 | ($1.85M) | May 20, 2024 |
Operating Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | ($6.88M) | Nov 14, 2025 |
| Q2 | 2025 | Jun 30, 2025 | ($4.84M) | Aug 18, 2025 |
| Q1 | 2025 | Mar 31, 2025 | ($5.00M) | May 15, 2025 |
| Q3 | 2025 | Sep 30, 2024 | ($2.44M) | Nov 14, 2025 |
| Q2 | 2025 | Jun 30, 2024 | ($779.8K) | Aug 18, 2025 |
| Q1 | 2025 | Mar 31, 2024 | ($630.2K) | May 15, 2025 |
| Q3 | 2024 | Sep 30, 2023 | ($622.2K) | Nov 15, 2024 |
| Q2 | 2024 | Jun 30, 2023 | ($1.52M) | Aug 14, 2024 |
| Q1 | 2024 | Mar 31, 2023 | ($1.05M) | May 20, 2024 |